UOB targets Japfa Comfeed Indonesia stock at IDR 2,900: Vaksindo sale totals IDR 1.81 trillion

Published on 10/15/2026 at 11:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Japfa sold Vaksindo for IDR 1.81 trillion on September 29, 2026. Deal equals 8.47 percent of June 2026 equity for Japfa Comfeed Indonesia stock.

Deal size and analyst view

Japfa transferred Vaksindo on September 29, 2026, in a IDR 1.81 trillion transaction.
UOB Kay Hian set a IDR 2,900 target on October 6, 2026.
The transaction equaled 8.47 percent of equity at June 30, 2026.

Japfa Comfeed Indonesia, ID1000126907, Illustration mit AI erstellt.

Japfa Comfeed Indonesia (ISIN ID1000126907) sold its entire holding in animal-health company Vaksindo for IDR 1.81 trillion, with the transaction effective on September 29, 2026, according to Bisnis.com. On October 6, 2026, UOB Kay Hian set a IDR 2,900 target for the stock while retaining a Buy view.

Vaksindo sale changes the portfolio

Japfa and its subsidiary Ciomas Adisatwa sold 31,000 Vaksindo shares, representing 100 percent of the issued and paid-up capital, to Japfa Pte. Ltd. and Bionovus Pte. Ltd. The transaction also transferred the Vaksindo, Vaksimune and Vitakur trademarks, Kontan reported on September 30, 2026.

The buyer group remains controlled by Japfa Pte. Ltd., which owns 56.34 percent of Japfa Comfeed Indonesia. That structure preserves the commercial relationship and supply chain while shifting Vaksindo outside Japfa's consolidated operations, according to Bisnis.com.

What does the deal mean?

The IDR 1.81 trillion transaction equaled 8.47 percent of Japfa's consolidated equity as of June 30, 2026. The company said the proceeds would support core businesses including animal feed, integrated poultry farming, aquaculture and processed food, while Vaksindo revenue, profit and assets would no longer be consolidated, Kontan reported.

UOB Kay Hian's October 6, 2026 update described the Cikupa complex as operating at full utilization and said Japfa was adding plants in Boyolali and Wonoayu plus a slaughterhouse in Nganjuk by the end of 2026. The house based its IDR 2,900 target on seven times estimated 2026 earnings, UOB Kay Hian said.

The stock's next test

The Jakarta listing stood at IDR 1,995 on October 15, 2026. UOB Kay Hian's IDR 2,900 target is 45.36 percent above that price, placing the analyst view well above the latest market level.